TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 77 filers reported holding TG THERAPEUTICS INC in Q4 2014. The put-call ratio across all filers is 0.21 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $2,100,272 | -0.3% | 84,552 | -39.6% | 0.39% | -6.0% |
| Q1 2023 | $2,106,126 | +7.6% | 140,035 | -15.4% | 0.41% | +2.2% |
| Q4 2022 | $1,957,238 | -30.8% | 165,447 | +182.0% | 0.40% | -4.9% |
| Q1 2021 | $2,828,000 | -16.7% | 58,675 | -10.1% | 0.43% | -23.4% |
| Q4 2020 | $3,394,000 | +31.4% | 65,245 | -32.4% | 0.56% | -9.2% |
| Q3 2020 | $2,582,000 | -15.1% | 96,480 | -38.2% | 0.61% | -8.9% |
| Q2 2020 | $3,041,000 | -16.7% | 156,084 | -49.3% | 0.67% | +38.6% |
| Q3 2017 | $3,651,000 | +16.0% | 308,120 | -1.6% | 0.48% | -6.7% |
| Q2 2017 | $3,148,000 | -18.4% | 313,187 | -5.4% | 0.52% | -14.5% |
| Q1 2017 | $3,856,000 | -43.4% | 330,950 | -19.4% | 0.61% | -23.7% |
| Q2 2015 | $6,813,000 | +9.5% | 410,689 | +2.2% | 0.80% | +10.8% |
| Q1 2015 | $6,221,000 | -8.8% | 401,875 | -6.7% | 0.72% | -24.5% |
| Q4 2014 | $6,821,000 | +151.8% | 430,627 | +69.6% | 0.95% | +73.1% |
| Q3 2014 | $2,709,000 | +111.5% | 253,893 | +86.1% | 0.55% | +126.3% |
| Q2 2014 | $1,281,000 | – | 136,392 | – | 0.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 726,200 | $3,086,000 | 3.46% |
| Paradigm Biocapital Advisors LP | 1,964,709 | $8,350,000 | 1.66% |
| 683 Capital Management, LLC | 3,300,000 | $14,025,000 | 0.99% |
| MAVERICK CAPITAL LTD | 6,747,549 | $28,677,000 | 0.71% |
| Antara Capital LP | 1,500,000 | $6,375,000 | 0.27% |
| Parkwood LLC | 47,168 | $1,375,000 | 0.24% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,677,500 | $11,379,000 | 0.24% |
| PURA VIDA INVESTMENTS, LLC | 950,813 | $4,041,000 | 0.24% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 567,576 | $2,412,000 | 0.20% |
| Antara Capital LP | 900,000 | $3,825,000 | 0.16% |